Inventor · disambiguated record
Joan Carboni
Also filed as: CARBONI JOAN · CARBONI JOAN M
11 granted patents·8 pending applications·256 citations·filing 2003–2020
92Inventor score
Top patents by PatentIndex Score
19 records- 0196US9771411B2Method of treating cancer by administering EGFR and EGFR/IGFIR binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 26, 2017·22 cites·20 claims
- 0296US9017655B2Bispecific EGFR/IGFIR binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Apr 28, 2015·36 cites·10 claims
- 0396US8343501B2Bispecific EGFR/IGFIR binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jan 1, 2013·45 cites·19 claims
- 0496US8221765B2Multivalent fibronectin based scaffold domain proteinsCAMPHAUSEN RAY·Filed 2009·Granted Jul 17, 2012·66 cites·20 claims
- 0595US9902762B2Multivalent fibronectin based scaffold domain proteinsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 27, 2018·28 cites·10 claims
- 0695US8728483B2Multivalent fibronectin based scaffold domain proteinsCAMPHAUSEN RAY·Filed 2012·Granted May 20, 2014·38 cites·29 claims
- 0792US10774130B2Method of treating cancer by administering multivalent fibronectin based scaffold domain proteinsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 15, 2020·6 cites·15 claims
- 0891US10183987B2Polynucleotides encoding bispecific EGFR/IGF-IR binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 22, 2019·7 cites·13 claims
- 0990US10954286B2Bispecific EGFR/IGFIR binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 23, 2021·2 cites·20 claims
- 1078US8492328B2Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulatorsHUANG FEI·Filed 2008·Granted Jul 23, 2013·4 cites·7 claims
- 1170US2021017252A1Multivalent fibronectin based scaffold domain proteinsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1260US7265260B2Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Sep 4, 2007·2 cites·11 claims
- 1353US2005075358A1Methods for treating IGF1R-inhibitor induced hyperglycemiaFiled 2004·Application pending·0 cites
- 1452US2004106605A1Synergistic methods and compositions for treating cancerFiled 2003·Application pending·0 cites
- 1552US2004072760A1Synergistic methods and compositions for treating cancerFiled 2003·Application pending·0 cites
- 1649US2004209930A1Synergistic methods and compositions for treating cancerFiled 2004·Application pending·0 cites
- 1748US2014309229A1Methods for selecting and treating cancer in patients with igf-1r/ir inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 1843US2012220594A1Methods for treating cancer in patients having igf-1r inhibitor resistanceHUANG FEI·Filed 2010·Application pending·0 cites
- 1938US2011123545A1Combination of vegfr2 and igf1r inhibitors for the treatment of proliferative diseasesBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →